Our results demonstrate that the D-type CDK inhibitor p18ink4c contributes to alloimmune T cell differentiation and function, and is required for graft-vs.-host disease and costimulation-resistant allograft rejection. Here, CDKN2C is linked to glycogen storage disease VI.